Bioten Co., Ltd. (XKON:289170)
South Korea · Delayed Price · Currency is KRW 3,405.00
+435.00 (14.65%)
At close: Jul 10, 2026
Bioten Market Cap
Bioten has a market cap or net worth of 12.18 billion as of July 10, 2026. Its market cap has decreased by -8.71% in one year.
Market Cap
12.18B
Enterprise Value
n/a
Revenue
10.71B
Ranking
n/a
PE Ratio
10.35
Stock Price
3,405.00
Market Cap Chart
Since October 13, 2023, Bioten's market cap has decreased from 23.56B to 12.18B, a decrease of -48.31%. That is a compound annual growth rate of -21.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 12.18B | -4.35% |
| Dec 30, 2025 | 12.73B | -29.50% |
| Dec 30, 2024 | 18.06B | 65.39% |
| Dec 28, 2023 | 10.92B | -53.65% |
| Oct 13, 2023 | 23.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seoul Pharma | 26.12B |
| Kyung Nam Pharm | 24.71B |
| Baskhanbio Pharma | 23.69B |
| Daesung Microbiological Labs. | 23.56B |
| BIFIDO | 21.51B |
| WooGene B&G | 21.25B |
| Hurum | 20.87B |
| Union Korea Pharm | 19.70B |